Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ends higher on AstraZeneca, oil stock boost; Just Eat Takeaway slumps

Wed, 21st Apr 2021 09:10

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Just Eat Takeaway.com slips as Uber Eats plans German
launch

* UK inflation edges up as COVID-19 price hit begins to ease

* UK home prices jump at fastest rate in six years in
February

* FTSE 100 up 0.6%, FTSE 250 slips 0.1%
(Updates to close)

By Devik Jain and Shashank Nayar

April 21 (Reuters) - London's FTSE 100 rose on Wednesday,
led by gains in AstraZeneca and energy heavyweights BP and Royal
Dutch Shell, while Just Eat Takeaway.com dropped following Uber
Eats' plan to foray into the German market.

Drugmaker AstraZeneca gained 1.7% and was the top
boost to the FTSE 100 after India's Serum Institute said it
would sell AstraZeneca vaccine to private hospitals at
$8/dose.

The blue-chip index rose 0.5%, with oil majors
and adding 1.4% and 1.2% respectively, after
Azerbaijan's energy ministry said BP's oil output was 5.9
million tonnes in the first quarter.

Meanwhile, traders assumed a rise in inflation in March
would have little impact on monetary policy after data showed
British consumer price inflation rose to 0.7% in March, while
prices charged by manufacturers rose by 1.9%, the highest in
nearly two years.

"For the Bank of England ... the fact that inflation is
likely to rise this year while the economic outlook is improving
suggests little imminent need to look at negative interest
rates," said James Smith, an economist at ING.

"The less exciting inflation story for 2022 suggests
policymakers will be in little rush to tighten policy, which we
don't expect to happen before 2023."

The FTSE 100 has gained 6.7% year-to-date on optimism about
a speedy economic recovery from the pandemic-driven recession,
although weighing on sentiment are concerns that central banks
would tighten monetary policy sooner than expected on prospects
of rising inflation.

British house prices rose at the fastest annual rate in more
than six years in February, data showed, pushing construction
and material stocks up 0.8%.

Just Eat Takeaway.com fell 2.7% after a media
report about rival Uber Eats' plan to start a food delivery
service in Germany, one of Just Eats’ most lucrative markets.

Entain gained 2.2% after BetMGM, a U.S. joint
venture with MGM Resorts, said it was targeting net
revenue of $1 billion in 2022.
(Reporting by Devik Jain in Bengaluru; editing by Uttaresh.V
and Elaine Hardcastle)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.